4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-

Request For Quotation
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Suppliers list
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ：65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Tel: 020-82000279 18988941452
Email: YN_research@163.com
Company Name: Suzhou Chenrui Biotechnology Co. LTD  
Tel: 17625585511
Email: 1580084073@qq.com
Company Name: Shaoyuan Technology (Shanghai) Co., Ltd.  
Tel: 021-50795510 4000665055
Email: marketing@accelachem.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Basic information
Product Name:4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-
Synonyms:4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-;Gcase activator 3;(S)-N-[(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl]-N-methyl-2-(3-pyridyl)quinazolin-4-amine
CAS:2270984-21-7
MF:C23H20N4O2
MW:384.43
EINECS:
Product Categories:
Mol File:2270984-21-7.mol
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Structure
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Chemical Properties
Boiling point 492.8±45.0 °C(Predicted)
density 1.277±0.06 g/cm3(Predicted)
pka4.74±0.30(Predicted)
Safety Information
MSDS Information
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Usage And Synthesis
UsesGcase activator 3 (compound 9Q) is a glucosidase (Glucosidase, GCase) activator that can partially stabilize GCase and increase its activity. Gcase activator 3 reduces mutant GCase protein misfolding and degradation in fibroblasts and dopaminergic midbrain neurons. Gcase activator 3 can be used in the study of Parkinson's disease (PD) and related synucleinopathies[1].
References[1] Zheng J, et al. Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase. J Med Chem. 2019 Feb 14;62(3):1218-1230. DOI:10.1021/acs.jmedchem.8b01294
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- Preparation Products And Raw materials
Tag:4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-(2270984-21-7) Related Product Information
4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- 2-(3,4-dimethoxyphenyl)-7-ethoxy-6-methoxy-N-(3-morpholin-4-ylpropyl)quinazolin-4-amine 4-Quinazolinamine, N-[(4-ethoxy-3-methoxyphenyl)methyl]-N-methyl-2-(3-pyridinyl)- 2-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-7-ethoxy-6-methoxy-N-methylquinazolin-4-amine GANGLIOSIDE GM1, AMMONIUM SALT, BOVINE Ganglioside GM1 (porcine brain) (sodium salt)